Page 1 | Search Results | The Journal of Immunology | American Association of Immunologists

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines

Lauren Taylor Hamilton, Yoshinobu Koguchi, Tanisha Christie, Takashi Shimada, Noriko Iwamoto, Bernie Fox, William L Redmond, Brian D Piening

J Immunol (2022) 208 (1_Supplement): 65.16.

https://doi.org/10.4049/jimmunol.208.Supp.65.16

Published: 01 May 2022

View article titled, Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines

Add to Citation Manager

Journal Articles

Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade is associated with induction of pro-inflammatory Tregs

Annah S Rolig, Elizabeth R Sturgill, Courtney Mick, Daniel Rose, Johanna Kaufmann, Niranjan Yanamandra, Sue Griffin, James Smothers, William L Redmond

J Immunol (2022) 208 (1_Supplement): 119.12.

https://doi.org/10.4049/jimmunol.208.Supp.119.12

Published: 01 May 2022

View article titled, Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade is associated with induction of pro-inflammatory Tregs

Add to Citation Manager

Journal Articles

Immunological profiling of tumor-infiltrating CD8⁺ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

William L Miller, Yoshinobu Koguchi, Johanna K Kaufmann, Niranjan Yanamandra, Sue Griffin, James Smothers, William L Redmond

J Immunol (2022) 208 (1_Supplement): 179.10.

https://doi.org/10.4049/jimmunol.208.Supp.179.10

Published: 01 May 2022

View article titled, Immunological profiling of tumor-infiltrating CD8+ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

Add to Citation Manager

Journal Articles

Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy

William L Redmond, Yoshinobu Koguchi, William L Miller, Tanisha Christie, Johanna Kaufmann, Laura Seestaller-Wehr, Niranjan Yanamandra, Sue Griffin, James Smothers

J Immunol (2022) 208 (1_Supplement): 179.14.

https://doi.org/10.4049/jimmunol.208.Supp.179.14

Published: 01 May 2022

View article titled, Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy

Add to Citation Manager

Journal Articles

Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8⁺ T Cell Development

Mohammad Farhad Amani, Annah S. Rolig, William L. Redmond

J Immunol (2020) 205 (7): 1857–1866.

https://doi.org/10.4049/jimmunol.1901052

Published: 01 October 2020

View article titled, Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8+ T Cell Development

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade (ICB) is associated with induction of pro-inflammatory Tregs

Elizabeth Rowland Sturgill, Courtney Mick, Johanna K Kaufmann, William L Redmond

J Immunol (2020) 204 (1_Supplement): 91.18.

https://doi.org/10.4049/jimmunol.204.Supp.91.18

Published: 01 May 2020

View article titled, Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade (ICB) is associated with induction of pro-inflammatory Tregs

Add to Citation Manager

Journal Articles

Dietary administration of alpha-tocopheryloxyacetic acid induces CD4⁺ T cell activation and prolongs survival in murine rhabdomyosarcoma

Christian M. Capitini, Fernanda Szewc, Sabrina A Kabakov, Sean P Rinella, Emmanuel Akporiaye, William L Redmond

J Immunol (2020) 204 (1_Supplement): 241.30.

https://doi.org/10.4049/jimmunol.204.Supp.241.30

Published: 01 May 2020

View article titled, Dietary administration of alpha-tocopheryloxyacetic acid induces CD4+ T cell activation and prolongs survival in murine rhabdomyosarcoma

Add to Citation Manager

Journal Articles

Efficacy of agonist αOX40 and antagonist αCTLA-4 cancer immunotherapy is increased by ibrutinib treatment through enhanced Eomes expression and T-cell response

Dana A Emerson, William L Redmond

J Immunol (2020) 204 (1_Supplement): 246.12.

https://doi.org/10.4049/jimmunol.204.Supp.246.12

Published: 01 May 2020

View article titled, Efficacy of agonist αOX40 and antagonist αCTLA-4 cancer immunotherapy is increased by ibrutinib treatment through enhanced Eomes expression and T-cell response

Add to Citation Manager

Journal Articles

The generation of memory CD8 T cells is regulated by intracellular Galectin-3

Mohammad Farhad, William L. Redmond

J Immunol (2018) 200 (1_Supplement): 47.2.

https://doi.org/10.4049/jimmunol.200.Supp.47.2

Published: 01 May 2018

View article titled, The generation of memory CD8 T cells is regulated by intracellular Galectin-3

Add to Citation Manager

Journal Articles

Toll-like receptor ligands in conjunction with agonist anti-OX40 mAb immunotherapy possess differential capacity to revive anergic self-reactive CD8 T cells

Melissa J. Kasiewicz, Mohammad Farhad, William L. Redmond

J Immunol (2016) 196 (1_Supplement): 215.4.

https://doi.org/10.4049/jimmunol.196.Supp.215.4

Published: 01 May 2016

View article titled, Toll-like receptor ligands in conjunction with agonist anti-OX40 mAb immunotherapy possess differential capacity to revive anergic self-reactive CD8 T cells

Add to Citation Manager

Journal Articles

Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature

Stefanie N Linch, Melissa J Kasiewicz, Michael J McNamara, Ian F Hilgart-Martiszus, Mohammad Farhad, Peter G Traber, William L Redmond

J Immunol (2016) 196 (1_Supplement): 75.9.

https://doi.org/10.4049/jimmunol.196.Supp.75.9

Published: 01 May 2016

View article titled, Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature

Add to Citation Manager

Journal Articles

The Apoptotic Pathway Contributing to the Deletion of Naive CD8 T Cells during the Induction of Peripheral Tolerance to a Cross-Presented Self-Antigen

William L. Redmond, Cheng-Hong Wei, Huub T. C. Kreuwel, Linda A. Sherman

J Immunol (2008) 180 (8): 5275–5282.

https://doi.org/10.4049/jimmunol.180.8.5275

Published: 15 April 2008

View article titled, The Apoptotic Pathway Contributing to the Deletion of Naive CD8 T Cells during the Induction of Peripheral Tolerance to a Cross-Presented Self-Antigen

Add to Citation Manager

Journal Articles

Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist

William L. Redmond, Michael J. Gough, Bridget Charbonneau, Timothy L. Ratliff, Andrew D. Weinberg

J Immunol (2007) 179 (11): 7244–7253.

https://doi.org/10.4049/jimmunol.179.11.7244

Published: 01 December 2007

View article titled, Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist

Add to Citation Manager

Journal Articles

CD8⁺ T Cell Tolerance in Nonobese Diabetic Mice Is Restored by Insulin-Dependent Diabetes Resistance Alleles

Xavier Martinez, Huub T. C. Kreuwel, William L. Redmond, Rebecca Trenney, Kara Hunter, Hugh Rosen, Nora Sarvetnick, Linda S. Wicker, Linda A. Sherman

J Immunol (2005) 175 (3): 1677–1685.

https://doi.org/10.4049/jimmunol.175.3.1677

Published: 01 August 2005

View article titled, CD8+ T Cell Tolerance in Nonobese Diabetic Mice Is Restored by Insulin-Dependent Diabetes Resistance Alleles

Add to Citation Manager

Journal Articles

Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo

William L. Redmond, Boris C. Marincek, Linda A. Sherman

J Immunol (2005) 174 (4): 2046–2053.

https://doi.org/10.4049/jimmunol.174.4.2046

Published: 15 February 2005

View article titled, Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo

Add to Citation Manager

Journal Articles

B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets

Deepak Yadav, Valeria Judkowski, Malin Flodstrom-Tullberg, Lori Sterling, William L. Redmond, Linda Sherman, Nora Sarvetnick

J Immunol (2004) 173 (6): 3631–3639.

https://doi.org/10.4049/jimmunol.173.6.3631

Published: 15 September 2004

View article titled, B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets

Add to Citation Manager

Journal Articles

Deletion of Naive CD8 T Cells Requires Persistent Antigen and Is Not Programmed by an Initial Signal from the Tolerogenic APC

William L. Redmond, Javier Hernandez, Linda A. Sherman

J Immunol (2003) 171 (12): 6349–6354.

https://doi.org/10.4049/jimmunol.171.12.6349

Published: 15 December 2003

View article titled, Deletion of Naive CD8 T Cells Requires Persistent Antigen and Is Not Programmed by an Initial Signal from the Tolerogenic APC

Add to Citation Manager

Journal Articles

Cutting Edge: T Cell-Mediated Pathology in Murine Lyme Borreliosis

Maureen D. McKisic, William L. Redmond, Stephen W. Barthold

J Immunol (2000) 164 (12): 6096–6099.

https://doi.org/10.4049/jimmunol.164.12.6096

Published: 15 June 2000

View article titled, Cutting Edge: T Cell-Mediated Pathology in Murine Lyme Borreliosis

Add to Citation Manager

NARROW

Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines

Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade is associated with induction of pro-inflammatory Tregs

Immunological profiling of tumor-infiltrating CD8⁺ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy

Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8⁺ T Cell Development

Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade (ICB) is associated with induction of pro-inflammatory Tregs

Dietary administration of alpha-tocopheryloxyacetic acid induces CD4⁺ T cell activation and prolongs survival in murine rhabdomyosarcoma

Efficacy of agonist αOX40 and antagonist αCTLA-4 cancer immunotherapy is increased by ibrutinib treatment through enhanced Eomes expression and T-cell response

The generation of memory CD8 T cells is regulated by intracellular Galectin-3

Toll-like receptor ligands in conjunction with agonist anti-OX40 mAb immunotherapy possess differential capacity to revive anergic self-reactive CD8 T cells

Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature

The Apoptotic Pathway Contributing to the Deletion of Naive CD8 T Cells during the Induction of Peripheral Tolerance to a Cross-Presented Self-Antigen

Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist

CD8⁺ T Cell Tolerance in Nonobese Diabetic Mice Is Restored by Insulin-Dependent Diabetes Resistance Alleles

Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo

B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets

Deletion of Naive CD8 T Cells Requires Persistent Antigen and Is Not Programmed by an Initial Signal from the Tolerogenic APC

Cutting Edge: T Cell-Mediated Pathology in Murine Lyme Borreliosis

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only